Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.29
-0.17 (-2.28%)
At close: Mar 6, 2026, 4:00 PM EST
7.43
+0.14 (1.92%)
After-hours: Mar 6, 2026, 5:35 PM EST
Adicet Bio Employees
Adicet Bio had 152 employees as of December 31, 2024. The number of employees increased by 9 or 6.29% compared to the previous year.
Employees
152
Change (1Y)
9
Growth (1Y)
6.29%
Revenue / Employee
n/a
Profits / Employee
-$756,671
Market Cap
73.67M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 152 | 9 | 6.29% |
| Dec 31, 2023 | 143 | 11 | 8.33% |
| Dec 31, 2022 | 132 | 46 | 53.49% |
| Dec 31, 2021 | 86 | 4 | 4.88% |
| Dec 31, 2020 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Fractyl Health | 101 |
| XBiotech | 88 |
| PolyPid | 73 |
| aTyr Pharma | 65 |
| AN2 Therapeutics | 22 |
| Cingulate | 13 |
| MediciNova | 13 |
ACET News
- 5 weeks ago - Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - Business Wire
- 2 months ago - Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones - Business Wire
- 2 months ago - Adicet Bio Announces Reverse Stock Split - Business Wire
- 3 months ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 months ago - Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire
- 4 months ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 months ago - Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference - Business Wire
- 5 months ago - Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA) - Business Wire